CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey. Show more

389 Interpace Pkwy, Parsippany, NJ, 07054, United States

Biotechnology

Healthcare

Market Cap

509.9M

52 Wk Range

$5.60 - $17.43

Previous Close

$6.40

Open

$6.40

Volume

1,899,270

Day Range

$6.22 - $6.49

Enterprise Value

510.3M

Cash

148.5M

Avg Qtr Burn

N/A

Insider Ownership

7.98%

Institutional Own.

55.15%

Qtr Updated

12/31/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
DefenCath® (taurolidine and heparin) Details Infectious disease, Catheter related blood stream infections	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DefenCath® (taurolidine and heparin) Details Infectious disease, Catheter related blood stream infections, TPN patients	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REZZAYO (rezafungin) Details Prophylaxis of Fungal Infections	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.